154 related articles for article (PubMed ID: 7799701)
1. Asthma deaths in New Zealand: whodunnit?
Blauw GJ; Westendorp RG
Lancet; 1995 Jan; 345(8941):2-3. PubMed ID: 7799701
[No Abstract] [Full Text] [Related]
2. Fenoterol and asthma mortality in New Zealand.
Pearce N; Crane J; Burgess C; Grainger J; Beasley R
N Z Med J; 1990 Feb; 103(884):73-5. PubMed ID: 2308729
[No Abstract] [Full Text] [Related]
3. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.
Beasley R; Pearce N; Crane J; Burgess C
Int Arch Allergy Immunol; 1995; 107(1-3):325-7. PubMed ID: 7613161
[TBL] [Abstract][Full Text] [Related]
4. Asthma and the beta agonist debate.
Crane J; Pearce N; Burgess C; Beasley R
Thorax; 1995 Sep; 50 Suppl 1(Suppl 1):S5-10. PubMed ID: 7570465
[No Abstract] [Full Text] [Related]
5. End of the New Zealand asthma mortality epidemic.
Pearce N; Beasley R; Crane J; Burgess C; Jackson R
Lancet; 1995 Jan; 345(8941):41-4. PubMed ID: 7799709
[TBL] [Abstract][Full Text] [Related]
6. The proper role of beta 2-adrenergic agonists in the treatment of children with asthma.
Furukawa CT; Kemp JP; Simons FE; Tinkelman DG
Pediatrics; 1992 Oct; 90(4):639-40. PubMed ID: 1357623
[No Abstract] [Full Text] [Related]
7. [Increased asthma fatality in chronic administration of beta agonists?].
Geisler LS
Dtsch Med Wochenschr; 1993 Feb; 118(6):206-7. PubMed ID: 8094666
[No Abstract] [Full Text] [Related]
8. [Beta 2 agonists in asthma therapy should be reevaluated--concerning the dosage].
Larsson K
Lakartidningen; 1991 Oct; 88(44):3643-5. PubMed ID: 1682539
[No Abstract] [Full Text] [Related]
9. The saga of the New Zealand asthma mortality epidemic.
N Z Med J; 1995 Mar; 108(995):91. PubMed ID: 7661939
[No Abstract] [Full Text] [Related]
10. End of New Zealand asthma epidemic.
Schuijt C; Staudinger H
Lancet; 1995 Feb; 345(8946):383-4. PubMed ID: 7845129
[No Abstract] [Full Text] [Related]
11. Risk of severe life threatening asthma.
Barnes NC; Kuitert LM
Thorax; 1996 Nov; 51(11):1073. PubMed ID: 8958886
[No Abstract] [Full Text] [Related]
12. Confounding by severity does not explain the association between fenoterol and asthma death.
Beasley R; Burgess C; Pearce N; Woodman K; Crane J
Clin Exp Allergy; 1994 Jul; 24(7):660-8. PubMed ID: 7953948
[TBL] [Abstract][Full Text] [Related]
13. Asthma. Bronchodilators: new developments.
Tattersfield AE
Br Med Bull; 1992 Jan; 48(1):190-204. PubMed ID: 1352168
[TBL] [Abstract][Full Text] [Related]
14. Beta 2-agonists and New Zealand asthma mortality.
Burgess C; Crane J; Pearce N; Beasley R
Lancet; 1991 Apr; 337(8747):982-3. PubMed ID: 1678066
[No Abstract] [Full Text] [Related]
15. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.
Crane J; Pearce N; Flatt A; Burgess C; Jackson R; Kwong T; Ball M; Beasley R
Lancet; 1989 Apr; 1(8644):917-22. PubMed ID: 2565417
[TBL] [Abstract][Full Text] [Related]
16. Routine use of beta-adrenergic agonists in asthma.
Wanner A; Sears MR
Am J Respir Crit Care Med; 1995 Aug; 152(2):823. PubMed ID: 7633750
[No Abstract] [Full Text] [Related]
17. Beta-agonists and death from asthma.
Pearce N; Crane J; Burgess C; Beasley R; Jackson R
N Engl J Med; 1992 Jul; 327(5):355-7. PubMed ID: 1352379
[No Abstract] [Full Text] [Related]
18. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.
Pearce N; Grainger J; Atkinson M; Crane J; Burgess C; Culling C; Windom H; Beasley R
Thorax; 1990 Mar; 45(3):170-5. PubMed ID: 2330548
[TBL] [Abstract][Full Text] [Related]
19. The use of beta-agonists and the risk of death and near death from asthma.
Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
[TBL] [Abstract][Full Text] [Related]
20. Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study.
Woodman K; Pearce N; Beasley R; Burgess C; Crane J
Clin Pharmacol Ther; 1992 May; 51(5):566-71. PubMed ID: 1587070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
